Status | Study |
Completed |
Study Name: Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia Condition: Measles Date: 2014-02-06 Interventions: Drug: Measles vaccine measles revaccination administered at 12 months from start of ART |
Recruiting |
Study Name: Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients Condition: Measles Date: 2013-01-15 Interventions: Biological: MMR vaccination Unprotected children will be vaccinated with two MMR vaccines |
Completed |
Study Name: Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso. Condition: Measles Vaccine Date: 2012-08-16 Interventions: Biological: Early measles vaccine |
Completed |
Study Name: Trial of Additional Measles Vaccine to Reduce Child Mortality Condition: Measles Vaccine Date: 2012-07-17 Interventions: Biological: Early measles vaccine Standard Edmonston-Zagreb measles vaccine |
Active, not recruiting |
Study Name: Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors Condition: Measles Date: 2012-05-16 |
Completed |
Study Name: A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices Condition: Prophylaxis for the Measles Infection Date: 2012-03-16 Interventions: Biological: PMV via Puffhaler® device |
Completed |
Study Name: Additional Measles Vaccine at 4 Months of Age Condition: Measles Infection Date: 2011-08-03 Interventions: Biological: Measles vaccine Edmonston-Zagreb measles vaccine |
Completed |
Study Name: Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years Condition: Measles Date: 2009-04-29 Interventions: Biological: MVA-mBN85B Low Dos |
Completed |
Study Name: Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer Condition: Non-Small Cell Lung Cancer Measles Date: 2009-01-22 Interventions: Biological: attenuated measles vaccine 4-week apart, two vaccines starting 4 weeks after last chemothera |
Recruiting |
Study Name: Ontogeny of Measles Immunity in Infants Condition: Measles Date: 2005-10-14 Interventions: Biological: Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous) |